Tenon Medical, Inc. (NASDAQ: TNON) repaid in full its outstanding original issue discount senior convertible promissory notes ahead of their September 11, 2026 maturity date, according to a company statement.

The notes, issued on March 11, 2026, carried an aggregate principal balance of approximately $5.16 million. The early repayment eliminates the possibility of the notes being converted into shares of common stock at a discount to market prices.

"By proactively addressing this obligation, we are reducing potential dilution for our shareholders, strengthening our financial position and maintaining greater flexibility to invest in the continued commercialization of our products and expansion of our business," said Steven M. Foster, President and Chief Executive Officer of Tenon Medical.

Tenon Medical is a medical device company that offers two systems for treating sacroiliac joint disorders: the Catamaran SI Joint Fusion System and the SImmetry+ SI Joint Fusion System, the latter acquired through an asset purchase from SiVantage, Inc. and SIMPL Medical, LLC in August 2025.